Attenuation of SRC Kinase Activity Augments PARP Inhibitor–mediated Synthetic Lethality in BRCA2-altered Prostate Tumors
暂无分享,去创建一个
P. Kantoff | M. Morris | W. Abida | D. Danila | L. Mucci | K. Stopsack | Subhiksha Nandakumar | G. Chakraborty | Rahim Hirani | G. Lee | Yuki Yoshikawa | Konrad H. Stopsack | Ying Z. Mazzu | Lina E. Jehane | M. Atiq | Nabeela Khan Patail | Rahim Hirani